Issue navigation
Volume 5, Issue 2, June 2023
Articles
The hereditary N363K POLE exonuclease mutant extends PPAP tumor spectrum to glioblastomas by causing DNA damage and aneuploidy in addition to increased mismatch mutagenicity
Guillaume Labrousse and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad011, https://doi.org/10.1093/narcan/zcad011
Discovering cryptic splice mutations in cancers via a deep neural network framework
Raphaël Teboul and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad014, https://doi.org/10.1093/narcan/zcad014
Molecular origins of mutational spectra produced by the environmental carcinogen N-nitrosodimethylamine and SN1 chemotherapeutic agents
Amanda L Armijo and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad015, https://doi.org/10.1093/narcan/zcad015
Deletion of the mRNA stability factor ELAVL1 (HuR) in pancreatic cancer cells disrupts the tumor microenvironment integrity
Grace A McCarthy and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad016, https://doi.org/10.1093/narcan/zcad016
HiTAIC: hierarchical tumor artificial intelligence classifier traces tissue of origin and tumor type in primary and metastasized tumors using DNA methylation
Ze Zhang and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad017, https://doi.org/10.1093/narcan/zcad017
Therapeutic disruption of RAD52–ssDNA complexation via novel drug-like inhibitors
Divya S Bhat and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad018, https://doi.org/10.1093/narcan/zcad018
Molecular mechanisms protecting centromeres from self-sabotage and implications for cancer therapy
Rim Nassar and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad019, https://doi.org/10.1093/narcan/zcad019
GSK-3484862 targets DNMT1 for degradation in cells
Qin Chen and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad022, https://doi.org/10.1093/narcan/zcad022
Current proteomics methods applicable to dissecting the DNA damage response
Monita Muralidharan and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad020, https://doi.org/10.1093/narcan/zcad020
Characterization of cell-type specific circular RNAs associated with colorectal cancer metastasis
Sidi Zhao and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad021, https://doi.org/10.1093/narcan/zcad021
Alterations of ribosomal RNA pseudouridylation in human breast cancer
Chiara Barozzi and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad026, https://doi.org/10.1093/narcan/zcad026
Over-expression of ADAR1 in mice does not initiate or accelerate cancer formation in vivo
Shannon Mendez Ruiz and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad023, https://doi.org/10.1093/narcan/zcad023
CrypticProteinDB: an integrated database of proteome and immunopeptidome derived non-canonical cancer proteins
Ghofran Othoum and Christopher A Maher
NAR Cancer, Volume 5, Issue 2, June 2023, zcad024, https://doi.org/10.1093/narcan/zcad024
Estrogen receptor alpha mutations regulate gene expression and cell growth in breast cancer through microRNAs
Spencer Arnesen and others
NAR Cancer, Volume 5, Issue 2, June 2023, zcad027, https://doi.org/10.1093/narcan/zcad027
Advertisement
Advertisement